Bernhard Greve

2.4k total citations
34 papers, 1.6k citations indexed

About

Bernhard Greve is a scholar working on Immunology, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Bernhard Greve has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Neurology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Bernhard Greve's work include Malaria Research and Control (9 papers), Myasthenia Gravis and Thymoma (7 papers) and T-cell and B-cell Immunology (7 papers). Bernhard Greve is often cited by papers focused on Malaria Research and Control (9 papers), Myasthenia Gravis and Thymoma (7 papers) and T-cell and B-cell Immunology (7 papers). Bernhard Greve collaborates with scholars based in Germany, United States and Canada. Bernhard Greve's co-authors include Ruprecht Schmidt‐Ott, Léopold G. Lehman, Doris Luckner, Bertrand Lell, Peter G. Kremsner, Peter Matousek, Klaus Herbich, D. Scott Schmid, Vijay K. Kuchroo and Adrian J. F. Luty and has published in prestigious journals such as Immunity, The Journal of Immunology and Neurology.

In The Last Decade

Bernhard Greve

34 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernhard Greve Germany	21	734	652	208	185	167	34	1.6k
Peter van der Meide Netherlands	21	635 0.9×	298 0.5×	289 1.4×	274 1.5×	86 0.5×	30	1.5k
Sally S. Atherton United States	28	530 0.7×	402 0.6×	57 0.3×	297 1.6×	77 0.5×	94	2.3k
Peter C. Charles United States	23	271 0.4×	370 0.6×	44 0.2×	542 2.9×	75 0.4×	31	1.6k
J I McGill United Kingdom	29	458 0.6×	642 1.0×	50 0.2×	328 1.8×	41 0.2×	63	2.2k
Valérie C. Asensio United States	23	1.3k 1.8×	161 0.2×	105 0.5×	339 1.8×	205 1.2×	26	2.5k
Beáta Polgár Hungary	25	1.3k 1.7×	501 0.8×	59 0.3×	211 1.1×	33 0.2×	51	1.8k
Stefan Fest Germany	23	1.1k 1.5×	374 0.6×	248 1.2×	564 3.0×	39 0.2×	42	1.9k
Denis G. Kay Canada	27	598 0.8×	184 0.3×	284 1.4×	726 3.9×	35 0.2×	41	2.0k
Y. Iwasaki Japan	21	317 0.4×	118 0.2×	156 0.8×	250 1.4×	144 0.9×	49	1.4k
Timothy W. Phares United States	22	576 0.8×	167 0.3×	93 0.4×	260 1.4×	181 1.1×	40	1.4k

Countries citing papers authored by Bernhard Greve

Since Specialization

Citations

This map shows the geographic impact of Bernhard Greve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Greve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Greve more than expected).

Fields of papers citing papers by Bernhard Greve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Greve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Greve. The network helps show where Bernhard Greve may publish in the future.

Co-authorship network of co-authors of Bernhard Greve

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Greve. A scholar is included among the top collaborators of Bernhard Greve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Greve. Bernhard Greve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bril, Vera, Julian Großkreutz, Ali A. Habib, et al.. (2025). Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions. Journal of Neuromuscular Diseases. 12(2). 218–230. 2 indexed citations

Habib, Ali A., Henry J. Kaminski, Julian Großkreutz, et al.. (2024). Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study (P4-11.001). Neurology. 102(7_supplement_1). 3311–3311. 1 indexed citations

Bril, Vera, John Vissing, Artur Drużdż, et al.. (2023). Rozanolixizumab responder and minimal symptom expression rates in generalized myasthenia gravis: Pooled phase 3 and extension studies. Journal of the Neurological Sciences. 455. 122016–122016. 1 indexed citations

Bril, Vera, Michael Benatar, Henning Andersen, et al.. (2020). Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis. Neurology. 96(6). e853–e865. 113 indexed citations

Szaflarski, Jerzy P., et al.. (2020). Randomized open-label trial of intravenous brivaracetam versus lorazepam for acute treatment of increased seizure activity. Epilepsy & Behavior. 109. 107127–107127. 10 indexed citations

Peter, Hans‐Hartmut, Hans D. Ochs, Charlotte Cunningham‐Rundles, et al.. (2020). Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations. Journal of Allergy and Clinical Immunology. 146(3). 479–491.e5. 82 indexed citations

Schmidt, Nils Ole, Arthur Melms, Makoto Dohi, et al.. (2013). Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells. Journal of Neuroinflammation. 10(1). 117–117. 22 indexed citations

Greve, Bernhard, Peter R. Hoffmann, Zsolt Illés, et al.. (2009). The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis. Human Immunology. 70(7). 540–542. 20 indexed citations

Greve, Bernhard, Reinhard Vonthein, Jürgen F. J. Kun, et al.. (2008). NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. Malaria Journal. 7(1). 251–251. 14 indexed citations

10.

Greve, Bernhard, Lalitha Vijayakrishnan, Raymond A. Sobel, et al.. (2004). The Diabetes Susceptibility Locus Idd5.1 on Mouse Chromosome 1 Regulates ICOS Expression and Modulates Murine Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 173(1). 157–163. 48 indexed citations

11.

Vijayakrishnan, Lalitha, Jacqueline M. Slavik, Zsolt Illés, et al.. (2004). An Autoimmune Disease-Associated CTLA-4 Splice Variant Lacking the B7 Binding Domain Signals Negatively in T Cells. Immunity. 20(5). 563–575. 175 indexed citations

12.

Greve, Bernhard, Jayagopala Reddy, Hanspeter Waldner, Raymond A. Sobel, & Vijay K. Kuchroo. (2004). Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H‐2^s congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes. European Journal of Immunology. 34(7). 1828–1838. 2 indexed citations

13.

Greve, Bernhard, et al.. (2002). Genetic background determines the requirement for B7 costimulation in induction of autoimmunity. European Journal of Immunology. 32(9). 2687–2697. 16 indexed citations

14.

Greve, Bernhard, Carl Magnusson, Arthur Melms, & Robert Weissert. (2001). Immunoglobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis. Journal of Neuroimmunology. 121(1-2). 120–125. 26 indexed citations

15.

Luty, Adrian J. F., Sebastian Ulbert, Bertrand Lell, et al.. (2000). Antibody responses to Plasmodium falciparum: evolution according to the severity of a prior clinical episode and association with subsequent reinfection.. American Journal of Tropical Medicine and Hygiene. 62(5). 566–572. 19 indexed citations

16.

Greve, Bernhard, Léopold G. Lehman, Bertrand Lell, et al.. (1999). High Oxygen Radical Production Is Associated with Fast Parasite Clearance in Children withPlasmodium falciparumMalaria. The Journal of Infectious Diseases. 179(6). 1584–1586. 73 indexed citations

17.

Lell, Bertrand, Jürgen May, Ruprecht Schmidt‐Ott, et al.. (1999). The Role of Red Blood Cell Polymorphisms in Resistance and Susceptibility to Malaria. Clinical Infectious Diseases. 28(4). 794–799. 141 indexed citations

18.

Luckner, Doris, Bertrand Lell, Bernhard Greve, et al.. (1998). No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection. Transactions of the Royal Society of Tropical Medicine and Hygiene. 92(5). 478–481. 36 indexed citations

19.

Schmidt‐Ott, Ruprecht, Léopold G. Lehman, Bertrand Lell, et al.. (1998). Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon. Transactions of the Royal Society of Tropical Medicine and Hygiene. 92(1). 110–114. 126 indexed citations

20.

Schmidt‐Ott, Ruprecht, Doris Luckner, Léopold G. Lehman, et al.. (1997). Pyrimethamine/sulfadoxine for treating uncomplicated Plasmodium falciparum malaria in young children in Gabon. Transactions of the Royal Society of Tropical Medicine and Hygiene. 91(5). 578–579. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact